Amneal Pharmaceuticals's total assets for Q4 2024 were $3.50B, an increase of 1.17% from the previous quarter. AMRX total liabilities were $2.42B for the fiscal quarter, a -30.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.